Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-014619

President and CEO acquired 288,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-28 Grant or award : show line 1 in the form +288,750 661,950 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-28 Grant or award : show line 2 in the form Stock Option (right to buy) +360,000 360,000 D
Loading xslF345X03/doc4.xml…